Cell Biotech Market Cap

Cell Biotech has a market cap or net worth of 98.55 billion as of April 1, 2026. Its market cap has increased by 7.62% in one year.

Market Cap

98.55B

Enterprise Value

5.92B

Revenue

53.13B

Ranking

n/a

PE Ratio

9.74

Stock Price

14,400.00

Market Cap Chart

Since March 3, 2003, Cell Biotech's market cap has increased from 13.97B to 98.55B, an increase of 605.56%. That is a compound annual growth rate of 8.83%.

Market Cap History

Date	Market Cap	% Change
Mar 31, 2026	95.81B	6.79%
Dec 30, 2025	89.72B	-8.13%
Dec 30, 2024	97.66B	27.18%
Dec 28, 2023	76.79B	-11.65%
Dec 29, 2022	86.92B	-34.80%
Dec 30, 2021	133.30B	-19.84%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BIO-FD&C	123.04B
ViGenCell	123.00B
CORESTEMCHEMON	112.45B
Quratis	108.73B
CHA Vaccine Research Institute	107.19B
NovMetaPharma	103.25B
TegoScience	101.60B
Progen	94.56B

Market Cap Rankings